EGFR and metastatic colorectal cancer: In the last decade, significant improvement in the treatment of several cancers (i.e., metastatic colorectal cancer, non-small cell lung cancer or head and neck SCC) has been obtained with the use of monoclonal anti-EGFR antibodies.